Anyway, the research showed that in mice, CBD was much more effective when used along with other compounds of the cannabis plant, than when it was used by itself. While they haven’t yet figured out why exactly this is the case, it’s now generally accepted that full-spectrum CBD oil is more effective at treating the majority of medical conditions, than is CBD isolate.
Full spectrum CBD, like hemp oil, contains every cannabinoid present in the cannabis plant. This means cannabidiol, cannabicyclol, tetrahydrocannabivarin, and cannbichromevinaric acid, to name a few. In full spectrum CBD oil, there is nothing held back or left out. These mixed together compliment each other and produce an entourage effect. This effect is good for the health of the user because the individual is taking all of the properties of all the terpenes and cannabinoid mixed together. All of these combined properties make the user absorbent of more effective effect and treatment. The treatment is very much beneficial for the health of the user hence that is why many users consider the full spectrum CBD far better than Isolate is CBD. Most products of CBD are from full-spectrum CBD.
Another major reason why CBD oil has been positively received in some parts of the medical community is its apparent effect on cancer and tumor growth.A study done by the researchers of the Institute of Toxicology and Pharmacology, University of Rostock, Germany recommends the use of CBD oil (even direct injection into tumors) to eliminate or reduce the size of the tumors. The antioxidants in CBD hemp oil also provide anti-mutagenic properties and lower users’ risk of cancer.
On a molecular level, all classes of cannabinoid are derived from the cannabinoid cannabigerol (CBG). Cannabinoids are changed from their original acid forms by decarboxylation through heat, light, or alkaline conditions, allowing them to interact fully with the endocannabinoid system. Learn more about all the cannabinoids found in our full spectrum hemp oil below:
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160